Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Ribbon Acquisition Corp.

CIK 2035016Updated Sep 24, 2026

RIBB price & chart

Provider market data

Loading TradingView…

NASDAQ:RIBB on TradingView ↗

TradingView · Data may be delayed

About the company

We are a blank check company incorporated in the Cayman Islands on July 17, 2024 as an exempted company with limited liability (meaning that our public shareholders have no liability, as shareholders of our company, for the liabilities of our company over and above the amount paid for their shares). We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to as a “target business.” Our efforts to identify a prospective target business will not be limited to a particular geographic location. We do not have any specific business combination under consideration and we have not (nor has anyone on our behalf), directly or indirectly, contacted any prospective target business or had any substantive discussions, formal or otherwise, with respect to such a transaction. Additionally, we have not engaged or retained any agent or other representative to identify or locate any suitable acquisition candidate, to conduct any research or take any measures, directly or indirectly, to locate or contact a target business.

424B4 · 2025-01-16 · 0001213900-25-003970

Company description from the cited filing.

In the news

No coverage from other publishers is available.

SEC disclosures

Recent filings

  1. Other Events

    Items 8.01

    8-K · 2026-09-17 · 0001213900-26-100982

  2. Other Events

    Items 8.01

    8-K · 2026-09-11 · 0001213900-26-099263

  3. Submission of Matters to a Vote of Security Holders

    Items 5.07

    8-K · 2026-09-11 · 0001213900-26-099253

  4. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities

    Items 1.01, 3.02, 9.01

    8-K · 2026-09-03 · 0001213900-26-096875

  5. Other Events

    Items 8.01

    8-K · 2026-08-17 · 0001213900-26-090771

Show 5 more recent filings
  1. 10-Q filing

    10-Q · 2026-08-14 · 0001213900-26-090076

  2. Other Events

    Items 8.01

    8-K · 2026-07-15 · 0001213900-26-078330

  3. Other Events

    Items 8.01

    8-K · 2026-06-10 · 0001213900-26-067335

  4. Other Events

    Items 8.01

    8-K · 2026-06-09 · 0001213900-26-066469

  5. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    Items 3.01

    8-K · 2026-06-05 · 0001213900-26-065883

Financials

FY 2025 · USD
Revenue · FY 2025
Net income690,218USD · FY 2025
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Operating income-1,258,096USD · FY 2025
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Diluted EPS · FY 2025

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025FY 2024
ASSETS
AssetsUSD51,999,143
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

508,662
Source

10-K · 2025-04-01 · 0001213900-25-026602

As of 2024-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD11,497
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

Assets, CurrentUSD50,829
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD2,607,002
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

Stockholders’ equity:
Retained Earnings (Accumulated Deficit)USD-344,465
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

-10,305
Source

10-K · 2025-04-01 · 0001213900-25-026602

As of 2024-12-31

Stockholders' Equity Attributable to ParentUSD-344,318
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

14,695
Source

10-K · 2025-04-01 · 0001213900-25-026602

As of 2024-12-31

Additional Paid in Capital, Common StockUSD24,875
Source

10-K · 2025-04-01 · 0001213900-25-026602

As of 2024-12-31

Liabilities and EquityUSD51,999,143
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

508,662
Source

10-K · 2025-04-01 · 0001213900-25-026602

As of 2024-12-31

Current liabilities:
Liabilities, CurrentUSD607,002
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

493,967
Source

10-K · 2025-04-01 · 0001213900-25-026602

As of 2024-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD192,002
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

229,025
Source

10-K · 2025-04-01 · 0001213900-25-026602

As of 2024-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025
Cash flows from operating activities:
Net Cash Provided by (Used in) Operating ActivitiesUSD-699,419
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD-50,000,000
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD50,710,916
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD11,497
Source

10-K · 2026-03-31 · 0001213900-26-037440

As of 2025-12-31

Additional Financial Items
Income Tax Expense (Benefit)USD0
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Investment Income, InterestUSD1,948,314
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Net Income (Loss) Attributable to ParentUSD690,218
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Operating ExpensesUSD1,258,096
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Proceeds from Issuance of Common StockUSD2,200,000
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025
Operating Income (Loss)USD-1,258,096
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Income Tax Expense (Benefit)USD0
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Net Income (Loss) Attributable to ParentUSD690,218
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Additional Financial Items
Investment Income, InterestUSD1,948,314
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Operating ExpensesUSD1,258,096
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Other General and Administrative ExpenseUSD10,000
Source

10-K · 2026-03-31 · 0001213900-26-037440

2025-01-01 to 2025-12-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-281806

424B4 · 2025-01-16 · 0001213900-25-003970

Terms from the governing filing for this registration; not a claim that the offering is open today.

Gross proceeds
50000000.0
Net proceeds
47000000.0
Deal price
10.0
Shares
5000000
Offering amount
$50,000,000
Offering price
market-price
Ticker
RIBBU

Filing attachments

ea024771401ex99-1_ribbon.htm · 8-K · 2025-07-01

EX-99.1 6 ea024771401ex99-1_ribbon.htm PRESS RELEASE, DATED AS OF JUNE 30, 2025 Exhibit 99.1 DRC Medicine Ltd. Announces the Business Combination Agreement with Ribbon Acquisition Corp. Combined Company Expected to be Listed on NASDAQ Global Market DRC Medicine Ltd. (“DRC Medicine” or the “Company”), is an innovative healthcare and biotechnology company headquartered in Japan, focused on the research, development, and commercialization of advanced medical technologies that address

8-K · 2025-07-01 · 0001213900-25-060364

Read attachment ↗
ea023432901ex99-1_ribbon.htm · 8-K · 2025-03-13

EX-99.1 2 ea023432901ex99-1_ribbon.htm PRESS RELEASE DATED MARCH 13, 2025 Exhibit 99.1 Ribbon Acquisition Corp Announces the Separate Trading of its Ordinary Shares and Rights New York, New York, March 13, 2025 (GLOBE NEWSWIRE) -- Ribbon Acquisition Corp (NASDAQ: RIBBU) (the “Company”) announced that, holders of the 5,000,000 units sold in the Company’s initial public offering may elect to separately trade the ordinary shares and rights included in the units, with such trading having comme

8-K · 2025-03-13 · 0001213900-25-023731

Read attachment ↗
ea022849401ex99-1_ribbon.htm · 8-K · 2025-01-23

EX-99.1 2 ea022849401ex99-1_ribbon.htm AUDITED BALANCE SHEET AS OF JANUARY 16, 2025 Exhibit 99.1 RIBBON ACQUISITION CORP. INDEX TO FINANCIAL STATEMENTS Content Page Report F-2 of Independent Registered Public Accounting Firm (Firm No. 3487) Balance F-3 Sheet as of January 16, 2025 Notes

8-K · 2025-01-23 · 0001213900-25-005999

Read attachment ↗
ea022775001ex4-1_ribbon.htm · 8-K · 2025-01-21

EX-4.1 4 ea022775001ex4-1_ribbon.htm RIGHTS AGREEMENT, DATED JANUARY 14, 2025, BY AND BETWEEN THE COMPANY AND ODYSSEY TRUST COMPANY Exhibit 4.1 RIGHTS AGENCY AGREEMENT RIGHTS AGENCY AGREEMENT (the “Agreement”), dated as of January 14, 2025 between Ribbon Acquisition Corp (the “Company”), A blank check company incorporated in the Cayman Islands as an exempted company, and Odyssey Transfer and Trust Company (the “Rights Agent” or “Odyssey”), a trust company incorporated under the laws of Min

8-K · 2025-01-21 · 0001213900-25-005031

Read attachment ↗
ea022775001ex99-1_ribbon.htm · 8-K · 2025-01-21

EX-99.1 12 ea022775001ex99-1_ribbon.htm PRESS RELEASE, DATED JANUARY 14, 2025 Exhibit 99.1 Ribbon Acquisition Corp Prices $50 Million Initial Public Offering New York, New York, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Ribbon Acquisition Corp, a blank check company incorporated in the Cayman Islands as an exempted company (the “Company”), today announced the pricing of its initial public offering (“IPO”) of 5,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one

8-K · 2025-01-21 · 0001213900-25-005031

Read attachment ↗
ea022775001ex99-2_ribbon.htm · 8-K · 2025-01-21

EX-99.2 13 ea022775001ex99-2_ribbon.htm PRESS RELEASE, DATED JANUARY 16, 2025 Exhibit 99.2 Ribbon Acquisition Corp Announces Closing of $50 Million Initial Public Offering. New York, New York, Jan. 16, 2025 -- Ribbon Acquisition Corp (NASDAQ: RIBBU, the “Company”) today announced the closing of its initial public offering (“IPO”) of 5,000,000 units at an offering price of $10.00 per unit. Each unit consists of one Class A ordinary share and one right to receive one-seventh (1/7) of one Cla

8-K · 2025-01-21 · 0001213900-25-005031

Read attachment ↗